What is FIECON?
FIECON is a health economics consultancy that’s all about respecting the technical and delivering the practical. Born from a desire to make a real difference, it was founded in 2015 by Kuntal Fisher and Mark Fisher, who brought together a decade of experience in pharmaceutical companies and healthcare consultancies. Since then, FIECON has grown from just two founders to a powerhouse team of over 100 professionals, serving some of the world’s largest pharmaceutical and biotech organisations. Their mission? To optimise business outcomes by harnessing the power of health economics, helping bring life-changing products to market.
Main Benefits and Key Figures
FIECON’s impact is impressive, and here’s a quick snapshot of what they’ve achieved and aspire to:
- Joined forces with Herspiegel in April 2025, becoming part of a global leader in pharmaceutical and biotech commercialisation services.
- United with Decisive Consulting in October 2025 to form the Global Value and Access Team, led by Senior Partner Esther Nzenza.
- Certified as a Great Place to Work® in November 2023.
- Achieved B Corporation® certification in July 2024.
- Aspiring to positively impact 100 million lives by 2030.
- Committed to giving back £10 million to wider societal causes by 2030.
FIECON’s Unique Approach
What sets FIECON apart? It’s their blend of commercial strategy and technical expertise — not one or the other, but both working hand in hand. They don’t just come up with ideas; they make sure those ideas actually work in the real world. Collaboration is key here. FIECON builds strong relationships with pharma, med tech, and biotech clients, supporting the commercialisation of products that truly change lives. Their approach is creative, practical, and results-driven — they keep going until solutions are implemented and delivering value.
Leadership and Expertise
The team at FIECON is packed with experts who bring deep knowledge and passion to the table. Leading the Global Value and Access Team is Esther Nzenza, a Senior Partner with a wealth of experience. Founders Kuntal Fisher (CEO) and Mark Fisher (COO) continue to steer the company with vision and dedication. Other key players include Mike Blackney (HEOR and Evidence), Richard Tolley (Value Communications and Capabilities), Chris Grimes Compton and Nic Gwatkin (Value Strategy), and Dawn Lee, Susan Suponcic, and Eric Low, who all contribute to making FIECON a trusted partner in the industry.
Client Testimonials and Reputation
Clients consistently praise FIECON for their flexibility, technical rigour, and commercial focus. One client said, “FIECON exceeds my expectations by genuinely trying to achieve the best outcomes for our company.” Another highlighted their role as a “reliable thought partner” who helps pressure test ideas beyond just health economics. The team’s strategic problem-solving is described as “a breath of fresh air,” with a strong emphasis on HTA knowledge and delivering the best solutions. Passion and creativity shine through in every project, giving clients the highest chance of success.
Project Impact and Sustainable Development Goals (SDGs)
- Good Health and Well-being (SDG 3)
- Decent Work and Economic Growth (SDG 8)
- Industry, Innovation, and Infrastructure (SDG 9)
- Reduced Inequalities (SDG 10)
- Partnerships for the Goals (SDG 17)
FIECON’s Vision for the Future
FIECON’s vision is clear: to use economics for the good of humanity. They aim to make a positive difference not just for their clients, but for their people and society at large. By 2030, they want to pioneer new ways workplaces operate, creating environments where people thrive and impact is maximised. Their core values guide everything they do, making FIECON not only a leader in health economics but also a great place to work and grow.
